These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 11327372
1. Measurements of bone turnover markers in premature infants. Shiff Y, Eliakim A, Shainkin-Kestenbaum R, Arnon S, Lis M, Dolfin T. J Pediatr Endocrinol Metab; 2001 Apr; 14(4):389-95. PubMed ID: 11327372 [Abstract] [Full Text] [Related]
2. The effect of neonatal sepsis on bone turnover in very-low birth weight premature infants. Eliakim A, Shiff Y, Nemet D, Dolfin T. J Pediatr Endocrinol Metab; 2003 Mar; 16(3):413-8. PubMed ID: 12705367 [Abstract] [Full Text] [Related]
6. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen. Katagiri M, Fukunaga M, Ohtawa T, Harada T. World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946 [Abstract] [Full Text] [Related]
11. Normal serum indices of bone collagen biosynthesis and degradation in small for gestational age infants. Namgung R, Tsang RC, Sierra RI, Ho ML. J Pediatr Gastroenterol Nutr; 1996 Oct; 23(3):224-8. PubMed ID: 8890070 [Abstract] [Full Text] [Related]
13. Abnormal bone turnover in monoclonal gammopathy of undetermined significance: analyses of type I collagen telopeptide, osteocalcin, bone-specific alkaline phosphatase and propeptides of type I and type III procollagens. Vejlgaard T, Abildgaard N, Jans H, Nielsen JL, Heickendorff L. Eur J Haematol; 1997 Feb; 58(2):104-8. PubMed ID: 9111591 [Abstract] [Full Text] [Related]
15. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency. Bollerslev J, Møller J, Thomas S, Djøseland O, Christiansen JS. Eur J Endocrinol; 1996 Dec; 135(6):666-71. PubMed ID: 9025710 [Abstract] [Full Text] [Related]
16. Antithyroid therapy improves bony manifestations and bone metabolic markers in patients with Graves' thyrotoxicosis. Nagasaka S, Sugimoto H, Nakamura T, Kusaka I, Fujisawa G, Sakuma N, Tsuboi Y, Fukuda S, Honda K, Okada K, Ishikawa S, Saito T. Clin Endocrinol (Oxf); 1997 Aug; 47(2):215-21. PubMed ID: 9302397 [Abstract] [Full Text] [Related]